De Novo Osteogenic Sarcoma of Mastoid Bone by Işikdogan, Abdurrahman et al.
Introduction
Osteosarcomas are the most common primary malig-
nant tumors of the bone.The appendicular skeleton,
in particular the long bones of the limbs, especially
the distal end of the femur and the proximal end of
the  tibia  are  the  most  common  primary  sites.
Osteosarcomas of the craniofacial bones are relatively
rare  and  represent less  than  10%  of  all  osteosar-
comas. The most commonly affected bones of the
head  are  the  mandible, followed  by  the  maxilla.
Osteosarcomas of extragnathic craniofacial bones are
very rare, constituting fewer than 2% of all osteosar-
comas.1,2We report a rare case of de novo osteogenic
sarcoma of the mastoid region of the temporal bone.
Case report
A 20-year-old man was admitted to a private medical
center in May 2001,with a history of extensive painful
swelling over the left temporo-mastoid region.He was
also  suffering  from  hearing  loss  in  the  left  ear.
Computed tomography  (CT)  scan  of  the  mastoid
showed a radio-dense mass with soft tissue density
areas which caused destruction of mastoid bone, was
extending to the external auditory canal. In addition,
there was a bony fragmentation in the lesion, and loss
of aeration in the mastoid bone (Fig. 1a).The tumor
was excised totally in the hospital. Histopathological
diagnosis was osteogenic sarcoma of the mastoid bone
(Fig. 2). He  was  referred  to  the  Department  of
Medical  Oncology  of Ybni  Sina  Hospital, Ankara
University, Faculty  of  Medicine, in  June  2001  for
further treatment.The patient had none of the predis-
posing factors, such as Paget’s disease of the bone,
radiotherapy  or  ￿ brous  dysplasia. There  was  no
abnormality on general physical examination except a
left  postauricular  incision  scar. Hematological  and
biochemical  parameters, including  serum  alkaline
phosphatase, were  normal. Postoperative  CT  scan
showed the  cavitation  due to surgical removal and
there  was  no  sign  of  macroscopic  residual  tumor 
(Fig. 1b). No metastatic lesions were noted on chest
CT  and  bone  scintigraphy. The  histopathological
slides were revised and the diagnosis of high-grade
medullary osteosarcoma was con￿ rmed (Fig. 2).The
combination chemotherapy regimen that we use for
conventional osteosarcoma, consisting of ifosfamide,
adriamycin, high-dose  methotrexate, and  cisplatin,
was  applied  as  adjuvant  treatment. Adjuvant
chemotherapy  was  completed  and  the  patient  has
been alive for 11 months without any recurrence of
the disease.
Discussion
We  present  an  aggressive  medullary  osteosarcoma
arising from an unusual site, the mastoid region of
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DOI: 10.1080/1357714021000022186the temporal bone, developed in a patient without
any predisposing condition.
Tumors  of  the  mastoidal  bone  are  uncommon,
with the exception of osteomas.1 Primary malignant
tumors  of  this  bone  are  very  rare. Osteogenic
sarcoma, which is the most common primary bone
tumor, rarely  occurs in  the  facial  and  the  cranial
bones. It  may  be  located  in  the  mandible  and
maxillae, but it is very rare in the temporal bone.2–4
Osteosarcomas  of  extragnathic  craniofacial  bones
constitute fewer than 2% of all osteosarcomas, and
less than 0.5%  of all primary  bone tumors. These
osteosarcomas may be ‘classic’ aggressive medullary
type or parosteal osteogenic sarcoma, which is a low-
grade  surface  bone tumor with  a  better  prognosis
than medullary osteogenic sarcoma.5,6
Nora et al. reported a series of 21  patients with
osteosarcomas  of  extragnathic  craniofacial  bones.2
They revised the archives of Mayo Clinic containing
nearly 7000 bone tumors, including 1000 osteosar-
comas,and only 21 cases affecting extragnathic cran-
iofacial bones were found.These tumors were located
over the entire calvarium The usual involved site was
the  occipital  bone. Only  one  of  these  cases  was
located at the temporo-sphenoid region.Salvatti et al.
also presented 19 cases of osteosarcoma of the skull,7
only one of which was located at the temporo-pari-
etal bone region. Sharma et al. reported a case  of
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Fig. 1. Computed tomography of temporal bones showed a mass of soft tissue that contained bone fragments, obliterating external
auditory meatus and subcutaneous fatty tissue:destruction of mastoid bone and the loss of aeration in mastoid cells on the left side (a)
and the cavitation in mastoidal bone after surgery (b).1
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classic  osteogenic  sarcoma of  the  temporal bone.4
Seely  and  Gates5 reported  two  cases  of  parosteal
osteosarcoma arising from mastoid bone,and Kumar
et  al.6 also  reported  eight  patients  with  parosteal
osteosarcoma of cranial bones,only two of them were
arising from the mastoid region.
The skull is a more common site for secondary
osteosarcomas. Paget’s disease and prior radiother-
apy are the most common predisposing conditions.
The rate of the secondary osteosarcoma in patients of
Nora et al.2 and Salvati et al.7 were reported as six of
21 (28%) and seven of 19 (36.8%), respectively. In
these two series, the authors had not classi￿ ed the
cases as aggressive medullary or parosteal osteosar-
comas,but the vast majority of these tumors were his-
tologically described as being highly malignant.
Parosteal osteosarcomas with typical radiological
appearance of sessile, densely ossi￿ ed surface growth
with  radiating  bone  spicules  that  blend  with
surrounding soft tissue are usually low grade lesions
and  en  bloc  resection  is  curative  in  most  cases.5,6
Medullary high-grade osteosarcoma of the craniofa-
cial region carries increased risk of local recurrences
and  distant  metastases.8 There  is  no  reason  to
manage  these  patients  in  a  different  way  from
conventional osteosarcomas.They should be treated
in  a  multidisciplinary  fashion, with  preoperative
chemotherapy  followed  by  radical  resection  and
adjuvant treatment, similar to the successful treat-
ment of conventional extremity osteosarcomas.Some
limited  experiences  have  already  appeared  in  the
literature.7,9,10 The dif￿ culty of radical resections in
this region and limited effectiveness of radiotherapy
in  osteosarcoma  may  increase  the  importance  of
effective neoadjuvant and adjuvant chemotherapy.
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Fig. 2. Histopathological examination of the mass in mastoid bone demonstrated many eosinophilic lace-like osteoid accumulations
with atypical osteoblasts surrounding them HE (200x).